CA2235393C - Compositions therapeutiques anti-angiogenese et procedes associes - Google Patents

Compositions therapeutiques anti-angiogenese et procedes associes Download PDF

Info

Publication number
CA2235393C
CA2235393C CA 2235393 CA2235393A CA2235393C CA 2235393 C CA2235393 C CA 2235393C CA 2235393 CA2235393 CA 2235393 CA 2235393 A CA2235393 A CA 2235393A CA 2235393 C CA2235393 C CA 2235393C
Authority
CA
Canada
Prior art keywords
endostatin
protein
angiogenesis
acid sequence
endostatin protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 2235393
Other languages
English (en)
Other versions
CA2235393A1 (fr
Inventor
Michael S. O'reilly
M. Judah Folkman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/740,168 external-priority patent/US5854205A/en
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Priority claimed from PCT/US1996/016925 external-priority patent/WO1997015666A1/fr
Publication of CA2235393A1 publication Critical patent/CA2235393A1/fr
Application granted granted Critical
Publication of CA2235393C publication Critical patent/CA2235393C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un inhibiteur de la prolifération des cellules endothéliales, capable d'inhiber l'angiogenèse et de provoquer une régression des tumeurs. Cet inhibiteur est d'environ 20 kDa et il correspond à un fragment C-terminal du collagène de type XVIII. L'invention concerne également des thérapies permettant de traiter des maladies liées à l'angiogénèse.
CA 2235393 1995-10-23 1996-10-23 Compositions therapeutiques anti-angiogenese et procedes associes Expired - Lifetime CA2235393C (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US583595P 1995-10-23 1995-10-23
US60/005,835 1995-10-23
US2307096P 1996-08-02 1996-08-02
US60/023,070 1996-08-02
US2626396P 1996-09-17 1996-09-17
US60/026,263 1996-09-17
US08/740,168 US5854205A (en) 1995-10-23 1996-10-22 Therapeutic antiangiogenic compositions and methods
US08/740,168 1996-10-22
PCT/US1996/016925 WO1997015666A1 (fr) 1995-10-23 1996-10-23 Compositions therapeutiques anti-angiogenese et procedes associes

Publications (2)

Publication Number Publication Date
CA2235393A1 CA2235393A1 (fr) 1997-05-01
CA2235393C true CA2235393C (fr) 2010-04-06

Family

ID=29408123

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2235393 Expired - Lifetime CA2235393C (fr) 1995-10-23 1996-10-23 Compositions therapeutiques anti-angiogenese et procedes associes

Country Status (1)

Country Link
CA (1) CA2235393C (fr)

Also Published As

Publication number Publication date
CA2235393A1 (fr) 1997-05-01

Similar Documents

Publication Publication Date Title
EP0857210B1 (fr) Compositions therapeutiques anti-angiogenese et procedes associes
US5854205A (en) Therapeutic antiangiogenic compositions and methods
US7867975B2 (en) Therapeutic antiangiogenic endostatin compositions
US6174861B1 (en) Methods of inhibiting angiogenesis via increasing in vivo concentrations of endostatin protein
AU3085699A (en) Metastatin and hyaluronate binding proteins and methods of use
AU2008201326B2 (en) Therapeutic antiangiogenic endostatin compositions
CA2235393C (fr) Compositions therapeutiques anti-angiogenese et procedes associes
US20040091465A1 (en) Therapeutic antiangiogenic compositions and methods
MXPA98003147A (en) Compositions of antiangiogenic therapeutic endostatine and methods of

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20161024